Immediate Impact
1 by Nobel laureates 57 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Karin Barchan being referenced
The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Karin Barchan | 35 | 93 | 32 | 104 | 101 | 14 | 334 | |
| Ellen B. Rest | 32 | 45 | 7 | 39 | 41 | 15 | 292 | |
| Amy E. Gilliam | 49 | 17 | 12 | 78 | 54 | 19 | 343 | |
| Frédéric Toussaint | 55 | 24 | 8 | 191 | 54 | 13 | 334 | |
| Zhijun Xia | 30 | 129 | 17 | 128 | 149 | 21 | 342 | |
| Ashley Levantine | 21 | 47 | 10 | 42 | 44 | 16 | 304 | |
| Herbert Ruebben | 43 | 117 | 32 | 58 | 38 | 20 | 340 | |
| Mohamed Gadelkarim | 43 | 43 | 17 | 48 | 43 | 17 | 325 | |
| Michael Feloney | 34 | 49 | 6 | 58 | 28 | 14 | 295 | |
| Ruyan Rahnama | 44 | 106 | 4 | 68 | 120 | 14 | 281 | |
| Anthony Rizzo | 103 | 19 | 22 | 31 | 53 | 15 | 362 |
All Works
Loading papers...